Is This Beaten-Down Tech Stock Worth Buying?
Teladoc Health (NYSE: TDOC) is disrupting the healthcare industry. Its virtual-first platform connects patients with clinicians across a broad range specialties, from primary care to chronic illnesses, making the experience more convenient and less costly. However, Teladoc shareholders have had a rough year -- despite strong sales growth in the first half of 2021, the stock price has fallen 53% from its all-time high.
In this Motley Fool Live video, which was recorded on Oct. 14, 2021, Fool.com contributor Rachel Warren shares her thoughts on Teladoc's upcoming third-quarter earnings report, which is scheduled for October 27. Rachel also explains her lasting conviction in this beaten-down tech stock.
Source Fool.com
